Mycoplasma genitalium: An Overlooked Sexually Transmitted Pathogen in Women?

Mycoplasma genitalium is a facultative anaerobic organism and a recognized cause of nongonococcal urethritis in men. In women, M. genitalium has been associated with cervicitis, endometritis, pelvic inflammatory disease (PID), infertility, susceptibility to human immunodeficiency virus (HIV), and ad...

Full description

Bibliographic Details
Main Authors: Samsiya Ona, Rose L. Molina, Khady Diouf
Format: Article
Language:English
Published: Hindawi Limited 2016-01-01
Series:Infectious Diseases in Obstetrics and Gynecology
Online Access:http://dx.doi.org/10.1155/2016/4513089
id doaj-ccd738d2f7aa4d3fbc080cd08a56c575
record_format Article
spelling doaj-ccd738d2f7aa4d3fbc080cd08a56c5752020-11-24T22:43:48ZengHindawi LimitedInfectious Diseases in Obstetrics and Gynecology1064-74491098-09972016-01-01201610.1155/2016/45130894513089Mycoplasma genitalium: An Overlooked Sexually Transmitted Pathogen in Women?Samsiya Ona0Rose L. Molina1Khady Diouf2Department of Obstetrics and Gynecology, Brigham and Women’s Hospital, 75 Francis Street, Boston, MA 02115, USADepartment of Obstetrics and Gynecology, Beth Israel Deaconess Medical Center, 330 Brookline Avenue, Boston, MA 02215, USADepartment of Obstetrics and Gynecology, Brigham and Women’s Hospital, 75 Francis Street, Boston, MA 02115, USAMycoplasma genitalium is a facultative anaerobic organism and a recognized cause of nongonococcal urethritis in men. In women, M. genitalium has been associated with cervicitis, endometritis, pelvic inflammatory disease (PID), infertility, susceptibility to human immunodeficiency virus (HIV), and adverse birth outcomes, indicating a consistent relationship with female genital tract pathology. The global prevalence of M. genitalium among symptomatic and asymptomatic sexually active women ranges between 1 and 6.4%. M. genitalium may play a role in pathogenesis as an independent sexually transmitted pathogen or by facilitating coinfection with another pathogen. The long-term reproductive consequences of M. genitalium infection in asymptomatic individuals need to be investigated further. Though screening for this pathogen is not currently recommended, it should be considered in high-risk populations. Recent guidelines from the Centers for Disease Control regarding first-line treatment for PID do not cover M. genitalium but recommend considering treatment in patients without improvement on standard PID regimens. Prospective studies on the prevalence, pathophysiology, and long-term reproductive consequences of M. genitalium infection in the general population are needed to determine if screening protocols are necessary. New treatment regimens need to be investigated due to increasing drug resistance.http://dx.doi.org/10.1155/2016/4513089
collection DOAJ
language English
format Article
sources DOAJ
author Samsiya Ona
Rose L. Molina
Khady Diouf
spellingShingle Samsiya Ona
Rose L. Molina
Khady Diouf
Mycoplasma genitalium: An Overlooked Sexually Transmitted Pathogen in Women?
Infectious Diseases in Obstetrics and Gynecology
author_facet Samsiya Ona
Rose L. Molina
Khady Diouf
author_sort Samsiya Ona
title Mycoplasma genitalium: An Overlooked Sexually Transmitted Pathogen in Women?
title_short Mycoplasma genitalium: An Overlooked Sexually Transmitted Pathogen in Women?
title_full Mycoplasma genitalium: An Overlooked Sexually Transmitted Pathogen in Women?
title_fullStr Mycoplasma genitalium: An Overlooked Sexually Transmitted Pathogen in Women?
title_full_unstemmed Mycoplasma genitalium: An Overlooked Sexually Transmitted Pathogen in Women?
title_sort mycoplasma genitalium: an overlooked sexually transmitted pathogen in women?
publisher Hindawi Limited
series Infectious Diseases in Obstetrics and Gynecology
issn 1064-7449
1098-0997
publishDate 2016-01-01
description Mycoplasma genitalium is a facultative anaerobic organism and a recognized cause of nongonococcal urethritis in men. In women, M. genitalium has been associated with cervicitis, endometritis, pelvic inflammatory disease (PID), infertility, susceptibility to human immunodeficiency virus (HIV), and adverse birth outcomes, indicating a consistent relationship with female genital tract pathology. The global prevalence of M. genitalium among symptomatic and asymptomatic sexually active women ranges between 1 and 6.4%. M. genitalium may play a role in pathogenesis as an independent sexually transmitted pathogen or by facilitating coinfection with another pathogen. The long-term reproductive consequences of M. genitalium infection in asymptomatic individuals need to be investigated further. Though screening for this pathogen is not currently recommended, it should be considered in high-risk populations. Recent guidelines from the Centers for Disease Control regarding first-line treatment for PID do not cover M. genitalium but recommend considering treatment in patients without improvement on standard PID regimens. Prospective studies on the prevalence, pathophysiology, and long-term reproductive consequences of M. genitalium infection in the general population are needed to determine if screening protocols are necessary. New treatment regimens need to be investigated due to increasing drug resistance.
url http://dx.doi.org/10.1155/2016/4513089
work_keys_str_mv AT samsiyaona mycoplasmagenitaliumanoverlookedsexuallytransmittedpathogeninwomen
AT roselmolina mycoplasmagenitaliumanoverlookedsexuallytransmittedpathogeninwomen
AT khadydiouf mycoplasmagenitaliumanoverlookedsexuallytransmittedpathogeninwomen
_version_ 1725694482971623424